Chiesi Recalls Zileuton Extended-Release Tablets Due to Dissolution Failure
Chiesi USA is recalling 2,598 bottles of Zileuton Extended-Release Tablets, 600 mg, because they failed dissolution specifications.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically involves a temporary or medically reversible adverse health consequence. The hazard is a failure to meet dissolution specifications, which is a quality control issue rather than a direct contamination or acute injury risk.
Plain-English summary
Chiesi USA, Inc. is recalling 2,598 bottles of Zileuton Extended-Release Tablets, 600 mg, 120-count bottles. The product is distributed by Prasco Laboratories in Mason, Ohio, and is available by prescription only. The recall covers lot 3171856 with an expiration date of 12/19.
The recall was initiated because the product failed to meet dissolution specifications. Dissolution is a test that measures how quickly a tablet breaks down and releases its active ingredient in the body. When this specification is not met, the medication may not work as intended.
The affected product was distributed nationwide in the USA. Consumers and healthcare providers should stop using the recalled product and contact their healthcare provider or pharmacist for guidance on replacement or alternative treatment.
The recalled product
- Product
- Zileuton Extended-Release Tablets, 600 mg, 120-count bottles, Rx only, Distributed by: Prasco Laboratories, Mason, OH 45040 USA; NDC 66993-485-32.
- Manufacturer
- Chiesi USA, Inc.
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 2,598
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lots: 3171856
- Exp. 12/19
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 2 recalled by Chiesi USA, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same manufacturer · Chiesi USA, Inc.
See all →- SevereCleviprex Injectable Emulsion Recall Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-07-22
- HighCurosurf intratracheal suspension recalled over lack of sterility assurance
FDA (Drugs) · 2026-04-01
- ModerateChiesi Recalls ZYFLO CR Tablets Due to Dissolution Failure
FDA (Drugs) · 2019-06-19
Same hazard · dissolution failure
See all →- ModerateApotex Recalls Paxil Tablets for Failed Dissolution and Stability Testing
FDA (Drugs) · 2026-09-02
- ModerateMylan Recalls Acamprosate Calcium Tablets Due to Dissolution Failure
FDA (Drugs) · 2026-08-26
- ModerateChlorthalidone 25mg tablets failed dissolution specifications in two batches
FDA (Drugs) · 2026-06-24
- ModerateNiacin extended-release tablets failed dissolution testing at 24 hours
FDA (Drugs) · 2026-06-17
- ModerateMinocycline extended-release tablets failed dissolution testing during stability analysis
FDA (Drugs) · 2026-06-17